RCC patient-derived peripheral blood mononuclear cells were injected into immunodeficient RCC-xenografted mice, followed by the transfer of autologous patient-derived TGFβ-resistant CD8+ T cells. This evidence concerns the gene CD8A and renal cell carcinoma.